Submitted:
07 May 2026
Posted:
08 May 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Computational Docking of Tryptamines to Tubulin
2.2. Excitation Energies and Transition Dipole Calculations
2.3. Hamiltonian and Exciton Analysis of the Tryptophan Network
2.4. Analysis Strategy
2.5. Ligand-Free-to-Ligand-Bound State Mapping and Perturbation Metrics
3. Results and Discussion
3.1. Computational Docking
3.2. Baseline Excitonic Structure of the Ligand-Free Tubulin Tryptophan Network
3.3. Ligand-Induced Perturbation of the Tryptophan Excitonic Manifold
4. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Akhmanova, A.; Steinmetz, M.O. Control of microtubule organization and dynamics: two ends in the limelight. Nat. Rev. Mol. Cell Biol. 2015, 16(12), 711–726. [Google Scholar] [CrossRef] [PubMed]
- Kapitein, L.C.; Hoogenraad, C.C. Building the neuronal microtubule cytoskeleton. Neuron 2015, 87(3), 492–506. [Google Scholar] [CrossRef] [PubMed]
- Craddock, T.J.A.; Friesen, D.; Mane, J.; Hameroff, S.; Tuszynski, J.A. The feasibility of coherent energy transfer in microtubules. J. R. Soc. Interface 2014, 11, 20140677. [Google Scholar] [CrossRef] [PubMed]
- Kurian, P.; Obisesan, T.O.; Craddock, T.J.A. Oxidative species-induced excitonic transport in tubulin aromatic networks: Potential implications for neurodegenerative disease. J. Photochem. Photobiol. B 2017, 175, 109–124. [Google Scholar] [CrossRef]
- Celardo, G.L.; Angeli, M.; Craddock, T.J.; Kurian, P. On the existence of superradiant excitonic states in microtubules. New J. Phys. 2019, 21, 023005. [Google Scholar] [CrossRef]
- Kalra, A.P.; Benny, A.; Travis, S.M.; Zizzi, E.A.; Morales-Sanchez, A.; Oblinsky, D.G.; Craddock, T.J.A.; Hameroff, S.; MacIver, B.; Tuszynski, J.A.; Petry, S.; Penrose, R.; Scholes, G.D. Electronic energy migration in microtubules. ACS Cent. Sci. 2023, 9, 352–361. [Google Scholar] [CrossRef] [PubMed]
- Babcock, N. S.; Montes-Cabrera, G.; Oberhofer, K. E.; Chergui, M.; Celardo, G. L.; Kurian, P. Ultraviolet superradiance from mega-networks of tryptophan in biological architectures. J. Phys. Chem. B 2024, 128(17), 4035–4046. [Google Scholar] [CrossRef] [PubMed]
- Craddock, T.J.A.; Hedrick, T.; De Abreu, I.R. Chemical-induced changes in the optical properties of aromatic amino acid lattices in protein polymers. In Quantum Effects and Measurement Techniques in Biology and Biophotonics Proceedings of SPIE; SPIE: Bellingham, WA, USA, 2024; Vol. 12863, p. 1286304. [Google Scholar] [CrossRef]
- Callis, P.R. Molecular orbital theory of the 1Lb and 1La states of indole. J. Chem. Phys. 1991, 95, 4230–4240. [Google Scholar] [CrossRef]
- Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B.A.; Thiessen, P.A.; Yu, B.; et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2019, 47, D1102–D1109. [Google Scholar] [CrossRef] [PubMed]
- Rose, P.W.; Prlić, A.; Altunkaya, A.; Bi, C.; Bradley, A.R.; Christie, C.H.; Costanzo, L.D.; Duarte, J.M.; Dutta, S.; Feng, Z.; et al. The RCSB Protein Data Bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017, 45, D271–D281. [Google Scholar] [CrossRef] [PubMed]
- Eberhardt, J.; Santos-Martins, D.; Tillack, A.F.; Forli, S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 2021, 61, 3891–3898. [Google Scholar] [CrossRef] [PubMed]
- Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30(16), 2785–2791. [Google Scholar] [CrossRef] [PubMed]
- Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; Li, X.; et al. Gaussian 16, Revision C.01; Gaussian, Inc.: Wallingford, CT, USA, 2016. [Google Scholar]
- Pierce, D.W.; Boxer, S.G. Stark effect spectroscopy of tryptophan. Biophys. J. 1995, 68, 1583–1591. [Google Scholar] [CrossRef] [PubMed]
- Abreu, I.R.; Barkdull, A.; Munoz, J.R.; Smith, R.P.; Craddock, T.J.A. A molecular analysis of substituted phenylethylamines as potential microtubule targeting agents through in silico methods and in vitro microtubule-polymerization activity. Sci. Rep. 2023, 13, 14406. [Google Scholar] [CrossRef] [PubMed]
- Craddock, T.J.A.; Tuszynski, J.A.; Chopra, D.; Casey, N.; Goldstein, L.E.; Hameroff, S.R.; Tanzi, R.E. The Zinc Dyshomeostasis Hypothesis of Alzheimer’s Disease. PLoS ONE 2012, 7(3), e33552. [Google Scholar] [CrossRef]
- Pellegrini, L.; Wetzel, A.; Grannó, S.; Heaton, G.; Harvey, K. Back to the tubule: microtubule dynamics in Parkinson’s disease. Cell Mol. Life Sci. 2017, 74(3), 409–434. [Google Scholar] [CrossRef] [PubMed]
- The PyMOL Molecular Graphics System, Version 3.0. Schrödinger, LLC.


| Name | Paclitaxel | Colchicine | Peloruside | Vinblastine | Maytansine | Pironetin | Gatorbulin |
|---|---|---|---|---|---|---|---|
| Solypertine | -7.708 | -9.855 | -7.836 | -7.617 | -7.506 | -8.818 | -9.224 |
| 3-(Et-Indole) Norfentanyl | -7.793 | -9.661 | -7.514 | -6.923 | -7.312 | -8.832 | -8.708 |
| LSD | -7.358 | -9.565 | -7.752 | -7.048 | -7.388 | -7.740 | -7.671 |
| E-6837 | -8.322 | -9.538 | -8.082 | -7.746 | -7.685 | -8.115 | -9.004 |
| Ibogaine | -7.543 | -9.184 | -7.646 | -8.217 | -7.723 | -8.450 | -8.695 |
| Alpertine | -7.394 | -9.090 | -7.165 | -7.459 | -6.378 | -8.278 | -8.336 |
| Milipertine | -7.673 | -9.050 | -7.822 | -6.811 | -7.124 | -7.549 | -8.716 |
| Oxypertine | -7.856 | -9.038 | -7.816 | -7.243 | -7.214 | -8.556 | -8.889 |
| Idalopirdine | -7.044 | -9.008 | -6.834 | -6.537 | -6.995 | -8.465 | -7.336 |
| FGIN-1-27 | -7.275 | -8.912 | -6.521 | -6.745 | -6.879 | -7.768 | -8.031 |
| 5-MeO-34MPEMT | -6.924 | -8.824 | -6.071 | -5.555 | -6.174 | -7.678 | -6.898 |
| HIOC | -7.228 | -8.815 | -7.424 | -6.819 | -7.191 | -8.403 | -8.416 |
| Benzotript | -7.353 | -8.793 | -7.891 | -7.452 | -7.406 | -8.429 | -8.301 |
| PRO-LAD | -7.378 | -8.719 | -7.762 | -7.175 | -7.470 | -7.607 | -7.225 |
| E-6801 | -7.120 | -8.715 | -6.449 | -6.836 | -6.788 | -7.769 | -7.829 |
| Moschamine | -7.494 | -8.585 | -7.294 | -7.769 | -6.934 | -8.369 | -8.402 |
| Exciton | Energy () | TRP1 | TRP2 | TRP3 | TRP4 | TRP5 | TRP6 | TRP7 | TRP8 |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 87.5 | -0.04 | 0.00 | 0.18 | -0.69 | -0.01 | -0.02 | 0.70 | -0.02 |
| 2 | 24.3 | -0.03 | 0.01 | 0.02 | -0.02 | 0.50 | 0.70 | 0.02 | 0.51 |
| 3 | 11.2 | 0.69 | 0.26 | -0.63 | -0.12 | -0.14 | 0.05 | 0.08 | 0.11 |
| 4 | 0.4 | -0.19 | 0.79 | -0.05 | 0.02 | 0.42 | -0.03 | 0.01 | -0.40 |
| 5 | -1.7 | 0.26 | -0.53 | -0.13 | -0.04 | 0.55 | 0.04 | 0.00 | -0.57 |
| 6 | -13.0 | 0.64 | 0.17 | 0.74 | 0.08 | 0.02 | 0.02 | -0.07 | -0.03 |
| 7 | -23.8 | 0.06 | -0.03 | -0.03 | 0.02 | 0.50 | -0.71 | 0.02 | 0.49 |
| 8 | -84.9 | 0.03 | -0.03 | -0.03 | 0.70 | -0.01 | 0.02 | 0.71 | -0.02 |
| Tryptamine | (nm) | (D) | Ligand coeff. | Interpretation | Largest () | Mean () | Largest eigvec change | Mean eigvec change |
|---|---|---|---|---|---|---|---|---|
| 3-(Et-Indole) Norfentanyl | 279.28 | 1.653 | 0.624 | appreciable mixing | 1.50 | 0.42 | 0.058 | 0.011 |
| 5-MeO-34MPEMT | 284.44 | 1.862 | 0.360 | appreciable mixing | 6.36 | 1.69 | 0.284 | 0.059 |
| Alpertine | 303.23 | 5.598 | 0.994 | mostly localized extra state | 1.68 | 0.47 | 0.001 | 0.001 |
| Benzotript | 274.38 | 2.001 | 0.664 | appreciable mixing | 4.44 | 1.10 | 0.223 | 0.047 |
| E-6801 | 284.72 | 0.885 | 0.560 | appreciable mixing | 1.15 | 0.36 | 0.053 | 0.013 |
| E-6837 | 302.27 | 1.756 | 0.999 | mostly localized extra state | 0.36 | 0.07 | 0.000 | 0.000 |
| FGIN-1-27 | 286.41 | 3.485 | 0.674 | appreciable mixing | 14.93 | 3.63 | 0.074 | 0.027 |
| HIOC | 290.00 | 2.036 | 0.653 | appreciable mixing | 1.21 | 0.50 | 0.086 | 0.014 |
| Ibogaine | 289.96 | 1.831 | 0.344 | appreciable mixing | 3.14 | 1.13 | 0.151 | 0.031 |
| Idalopirdine | 276.80 | 1.798 | 0.814 | appreciable mixing | 2.16 | 0.60 | 0.066 | 0.014 |
| LSD | 310.13 | 3.965 | 0.999 | mostly localized extra state | 0.86 | 0.17 | 0.000 | 0.000 |
| Milipertine | 290.74 | 1.835 | 0.388 | appreciable mixing | 2.57 | 0.78 | 0.146 | 0.030 |
| Moschamine | 286.54 | 1.713 | 0.651 | appreciable mixing | 0.79 | 0.24 | 0.062 | 0.009 |
| Oxypertine | 279.75 | 1.622 | 0.715 | appreciable mixing | 1.33 | 0.43 | 0.030 | 0.006 |
| PRO-LAD | 276.23 | 2.085 | 0.395 | appreciable mixing | 4.06 | 1.16 | 0.210 | 0.051 |
| Solypertine | 286.07 | 2.800 | 0.819 | appreciable mixing | 1.79 | 0.38 | 0.016 | 0.002 |
| Tryptamine | (nm) | (D) | Ligand coeff. | Interpretation | Largest () | Mean () | Largest eigvec change | Mean eigvec change |
|---|---|---|---|---|---|---|---|---|
| 3-(Et-Indole) Norfentanyl | 282.89 | 1.579 | 0.535 | appreciable mixing | 1.59 | 0.48 | 0.088 | 0.015 |
| 5-MeO-34MPEMT | 288.03 | 1.809 | 0.370 | appreciable mixing | 6.09 | 1.62 | 0.270 | 0.056 |
| Alpertine | 305.11 | 5.618 | 0.998 | mostly localized extra state | 0.95 | 0.28 | 0.001 | 0.000 |
| Benzotript | 277.12 | 2.030 | 0.292 | appreciable mixing | 4.45 | 1.45 | 0.251 | 0.056 |
| E-6801 | 310.29 | 1.247 | 1.000 | mostly localized extra state | 0.04 | 0.01 | 0.000 | 0.000 |
| E-6837 | 311.44 | 1.841 | 1.000 | mostly localized extra state | 0.08 | 0.03 | 0.000 | 0.000 |
| FGIN-1-27 | 289.13 | 3.518 | 0.674 | appreciable mixing | 14.87 | 3.64 | 0.074 | 0.027 |
| HIOC | 293.71 | 1.971 | 0.647 | appreciable mixing | 1.16 | 0.47 | 0.092 | 0.014 |
| Ibogaine | 292.27 | 1.793 | 0.352 | appreciable mixing | 2.97 | 1.09 | 0.150 | 0.030 |
| Idalopirdine | 280.61 | 1.771 | 0.815 | appreciable mixing | 2.11 | 0.61 | 0.061 | 0.013 |
| LSD | 314.50 | 3.983 | 1.000 | mostly localized extra state | 0.64 | 0.12 | 0.000 | 0.000 |
| Milipertine | 281.43 | 1.777 | 0.306 | appreciable mixing | 4.58 | 1.26 | 0.205 | 0.053 |
| Moschamine | 290.30 | 1.672 | 0.665 | appreciable mixing | 0.74 | 0.23 | 0.057 | 0.008 |
| Oxypertine | 281.74 | 2.258 | 0.490 | appreciable mixing | 1.59 | 0.54 | 0.094 | 0.021 |
| PRO-LAD | 279.59 | 2.007 | 0.395 | appreciable mixing | 3.86 | 1.10 | 0.228 | 0.051 |
| Solypertine | 289.85 | 2.866 | 0.739 | appreciable mixing | 1.86 | 0.51 | 0.086 | 0.013 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).